Spoken Alpha
ICU
SeaStar Medical Holding Corp
Overview
SeaStar Medical Holding Corp is a Healthcare company operating in Biotechnology with a $13.0M market cap.
ICU missed consensus EPS by 0.1% in Q1 FY2026, reported May 13, 2026.
3 earnings calls indexed on Spoken Alpha.
Behavioral analysis
Management language signature
Disclosures
Investor Relations
Extracted from Unknown source, 2026-06-21.
Transcripts
Recent earnings calls
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
History
Earnings history
- Q1 FY20262026-05-13EPS$-0.90 vs $-0.82-9.1%Rev$495.0K vs ——EODHD
- Q4 FY20252026-03-25EPS$-0.80 vs $-1.01+21.2%Rev$420.0K vs ——EODHD
- Q3 FY20252025-11-12EPS$-0.13 vs $-0.34+61.8%Rev$183.0K vs ——EODHD
- Q2 FY20252025-08-12EPS$-0.18 vs $-0.40+55.0%Rev$338.0K vs ——EODHD
- Q1 FY20252025-05-13EPS$-0.44 vs $-0.62+29.0%Rev$293.0K vs ——EODHD
- Q4 FY20242025-03-26EPS$-0.90 vs $-0.18-100.0%Rev$67.0K vs ——EODHD
- Q3 FY20242024-11-11EPS$-1.10 vs $-1.13+2.6%Rev$68.0K vs ——EODHD
- Q2 FY20242024-08-12EPS$-1.03 vs $-1.41+27.0%Rev$0 vs ——EODHD
- Q1 FY20242024-05-13EPS$-0.19 vs $-0.15-26.7%Rev$0 vs ——EODHD
- Q4 FY20232024-03-12EPS$-0.22 vs $-0.13-69.2%Rev$0 vs ——EODHD
- Q3 FY20232023-11-13EPS$-0.36 vs $-0.25-44.0%Rev$0 vs ——EODHD
- Q2 FY20232023-08-13EPS$-0.28 vs $-0.25-12.0%Rev$0 vs ——EODHD
- Q1 FY20232023-05-14EPS$-0.40 vs ——Rev$0 vs ——EODHD
- Q4 FY20222023-03-29EPS$-2.04 vs ——Rev$0 vs ——EODHD
- Q3 FY20222022-11-13EPS$-0.05 vs ——Rev$0 vs ——EODHD
- Q2 FY20222022-08-15EPS$0.01 vs ——Rev$0 vs ——EODHD
- Q1 FY20222022-04-05EPS$0.01 vs ——Rev$0 vs ——EODHD
- Q4 FY20212021-12-30EPS$2.22 vs ——Rev— vs ——EODHD
- Q3 FY20212021-11-16EPS$0.02 vs ——Rev— vs ——EODHD
- Q2 FY20212021-08-15EPS$-0.15 vs ——Rev— vs ——EODHD
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q1 FY2026 | 2026-05-13 | $-0.90 | $-0.82 | -9.1% | $495.0K | — | — | EODHD |
| Q4 FY2025 | 2026-03-25 | $-0.80 | $-1.01 | +21.2% | $420.0K | — | — | EODHD |
| Q3 FY2025 | 2025-11-12 | $-0.13 | $-0.34 | +61.8% | $183.0K | — | — | EODHD |
| Q2 FY2025 | 2025-08-12 | $-0.18 | $-0.40 | +55.0% | $338.0K | — | — | EODHD |
| Q1 FY2025 | 2025-05-13 | $-0.44 | $-0.62 | +29.0% | $293.0K | — | — | EODHD |
| Q4 FY2024 | 2025-03-26 | $-0.90 | $-0.18 | -100.0% | $67.0K | — | — | EODHD |
| Q3 FY2024 | 2024-11-11 | $-1.10 | $-1.13 | +2.6% | $68.0K | — | — | EODHD |
| Q2 FY2024 | 2024-08-12 | $-1.03 | $-1.41 | +27.0% | $0 | — | — | EODHD |
| Q1 FY2024 | 2024-05-13 | $-0.19 | $-0.15 | -26.7% | $0 | — | — | EODHD |
| Q4 FY2023 | 2024-03-12 | $-0.22 | $-0.13 | -69.2% | $0 | — | — | EODHD |
| Q3 FY2023 | 2023-11-13 | $-0.36 | $-0.25 | -44.0% | $0 | — | — | EODHD |
| Q2 FY2023 | 2023-08-13 | $-0.28 | $-0.25 | -12.0% | $0 | — | — | EODHD |
| Q1 FY2023 | 2023-05-14 | $-0.40 | — | — | $0 | — | — | EODHD |
| Q4 FY2022 | 2023-03-29 | $-2.04 | — | — | $0 | — | — | EODHD |
| Q3 FY2022 | 2022-11-13 | $-0.05 | — | — | $0 | — | — | EODHD |
| Q2 FY2022 | 2022-08-15 | $0.01 | — | — | $0 | — | — | EODHD |
| Q1 FY2022 | 2022-04-05 | $0.01 | — | — | $0 | — | — | EODHD |
| Q4 FY2021 | 2021-12-30 | $2.22 | — | — | — | — | — | EODHD |
| Q3 FY2021 | 2021-11-16 | $0.02 | — | — | — | — | — | EODHD |
| Q2 FY2021 | 2021-08-15 | $-0.15 | — | — | — | — | — | EODHD |
Source: EODHD. ICU reported actuals as published; sparse fields render as —.
Track Record
SampleSpoken Alpha tracks ICU's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Beats consensus 10/10 quarters with 70% positive reaction rate
SampleConsistent execution against consensus with the stock following through is the cleanest signal a guidance regime is calibrated. Worth watching for the inflection where execution deteriorates relative to the bar.
Raised guidance 8 quarters in a row
SampleConsecutive raises tighten the bar quarter over quarter. Watch the most recent print for the magnitude of the beat — a smaller beat against a higher bar is the early signal that the regime is breaking.
Quarterly beats & misses
Sample| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $5.53 | $4.31 | +28.3% | +1.7% | -0.8% |
| Q4 FY2026 | $5.49 | $4.12 | +33.2% | +6.1% | +6.9% |
| Q3 FY2026 | $5.52 | $4.12 | +34.0% | -2.7% | -3.9% |
| Q2 FY2026 | $5.96 | $4.35 | +37.0% | +7.9% | +7.5% |
| Q1 FY2025 | $5.33 | $4.26 | +25.1% | +3.3% | +1.2% |
| Q4 FY2025 | $5.42 | $4.26 | +27.3% | +5.8% | +8.4% |
| Q3 FY2025 | $5.19 | $4.17 | +24.5% | 0.0% | +2.4% |
| Q2 FY2025 | $5.87 | $4.27 | +37.4% | +3.7% | +6.1% |
| Q1 FY2024 | $5.91 | $4.45 | +32.9% | +7.3% | +9.7% |
| Q4 FY2024 | $5.74 | $4.35 | +32.0% | -0.5% | +1.3% |
Guidance change history
Sample- Q1 FY2026Raised2026-04-15
- Q4 FY2026Raised2026-13-15
- Q3 FY2026Raised2026-10-15
- Q2 FY2026Raised2026-07-15
- Q1 FY2025Raised2025-04-15
- Q4 FY2025Raised2025-13-15
- Q3 FY2025Raised2025-10-15
- Q2 FY2025Raised2025-07-15
Top executives
SampleSpoken Alpha builds an accountability record per executive — how the person's own guidance, language, and reactions have evolved across every call they've appeared on. The one-liners below are illustrative placeholder data pending the deviation v1 work. Click any name for the full role timeline and call appearance history.
- Eric SchlorffCEO1 yr 7 mo3 callsCurrentSample
CEO since 2024 • 4/8 beats (50%) • last guidance raise Q3 FY2026
- Michael MessingerCFO7 mo1 callCurrentSample
CFO since 2025 • 3/4 beats (75%) • guidance suspended Q2 FY2026
- Kevin ChungChief Medical Officer1 yr 9 mo3 callsCurrentSample
OTHER_C_SUITE since 2024 • 5/8 beats (63%) • last guidance raise Q1 FY2026
- Bradford K TownePrincipal Accounting Officer10 mono recorded callsCurrentSample
OTHER since 2025 • 3/4 beats (75%) • guidance suspended Q3 FY2026
- David A GreenCFO1 yr1 callFormerSample
CFO since 2024 • 6/8 beats (75%) • last guidance cut Q2 FY2026
Peers
Other companies in Healthcare
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
For developers and AI agents
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for ICU.
$ curl https://api.spokenalpha.com/v1/companies/ICUFAQ
Frequently asked about ICU
Where can I find SeaStar Medical Holding Corp's (ICU) earnings call transcripts?
Spoken Alpha indexes ICU's earnings call transcripts at https://spokenalpha.com/companies/ICU. Each call links to attributed speakers and parsed analyst Q&A.
When was SeaStar Medical Holding Corp's most recent earnings call?
SeaStar Medical Holding Corp (ICU) held its most recent earnings call on 2026-05-13, covering fiscal Q1 2026.
What sector is ICU in?
SeaStar Medical Holding Corp (ICU) operates in the Healthcare sector (Biotechnology industry).